Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Berberine is an isoquinoline alkaloid extracted from medicinal herbs, has been demonstrated
to produce beneficial effects on diabetes and hyperlipidemia, fewer study reported its
modification on lipid metabolism in schizophrenia. Metformin, have been used for metabolic
abnormalities in schizophrenia, findings from these studies indicated that they did have some
effect,which are still in experimental stage.This study is aim to compare the efficacy and
safety of berberine and metformin for preventing metabolic dysfunction in schizophrenia
patients.